Why the study?
Does withdrawal of amantadine precipitate neuroleptic malignant syndrome in hyperpyrexic patients?
Does withdrawal of amantadine precipitate neuroleptic malignant syndrome in hyperpyrexic patients?
Dopamine agonists should not be discontinued in hyperpyrexic patients at risk for neuroleptic malignant syndrome.
Answers are grounded in this paper and cite their sources.
Supports avoiding abrupt amantadine withdrawal in neuroleptic-treated patients; hypothesis-generating case report requiring confirmation.
Withdrawal of dopamine agonists may precipitate or exacerbate neuroleptic malignant syndrome. This case report of neuroleptic malignant syndrome following withdrawal of neuroleptics and amantadine suggests that dopamine agonists should not be discontinued in hyperpyrexic patients at risk for this syndrome.
No takes yet. Share an insight, caveat, or question.
Simpson et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: